Uni-Bio Science Group Limited
UNBSF
$0.00
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 12.92% | 13.31% | -50.85% | -50.94% | 71.49% |
| Total Depreciation and Amortization | 16.56% | 16.95% | -25.85% | -25.99% | 41.51% |
| Total Amortization of Deferred Charges | -- | -- | 816.73% | 813.88% | -- |
| Total Other Non-Cash Items | -25.54% | -25.97% | 115.61% | 115.21% | -44.87% |
| Change in Net Operating Assets | -- | -- | -691.93% | -690.87% | -- |
| Cash from Operations | 7.99% | 8.37% | -81.44% | -81.48% | 78.56% |
| Capital Expenditure | -- | -- | 36.07% | 36.19% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 342.45% | 343.30% | -2,962.71% | -2,957.65% | -82.04% |
| Cash from Investing | 342.45% | 343.30% | -135.62% | -135.18% | -82.04% |
| Total Debt Issued | -- | -- | 53.88% | 53.88% | -- |
| Total Debt Repaid | -- | -- | -16.64% | -16.64% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -380.61% | -380.61% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -214.75% | -214.75% | -1,759.61% | -1,759.61% | 3,839.19% |
| Cash from Financing | -214.94% | -215.35% | -89.64% | -89.66% | 3,851.22% |
| Foreign Exchange rate Adjustments | 44.97% | 44.78% | 1,219.06% | 1,216.92% | -38.41% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 327.38% | 328.88% | -367.67% | -367.18% | 1,140.53% |